These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3299304)

  • 1. [Role of aminoglutethimide in the treatment of adrenal hyperfunction].
    Kasperlik-Załuska A; Migdalska B; Jeske W; Wiśniewska-Woźniak T
    Pol Arch Med Wewn; 1986 Dec; 76(5-6):249-57. PubMed ID: 3299304
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary results of treatment of hypercorticism with aminoglutethimide].
    Chen JL
    Zhonghua Nei Ke Za Zhi; 1982 Dec; 21(12):747-9, 777-8. PubMed ID: 7182138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of aminoglutethimide in the treatment of Cushing's syndrome].
    Jacobelli A; Borgia MC; Borgia C; Sellini M
    Minerva Med; 1974 Jan; 65(3):156-62. PubMed ID: 4370585
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
    Hamilton W
    Q J Med; 1971 Oct; 40(160):568-9. PubMed ID: 5157412
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of aminoglutethimide in the treatment of adrenal gland hyperfunction].
    Neumann P; Knappe G; Stahl F; Kublun G; Bruns W; Wulfert P
    Z Gesamte Inn Med; 1979 May; 34(9):247-53. PubMed ID: 225896
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.
    Cash R; Brough AJ; Cohen MN; Satoh PS
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1239-48. PubMed ID: 4292247
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of ACTH Paraneoplastic syndrome with aminoglutethimide.
    Vaughn CB; Pearson S; Chapman J; Chinn B; Banks D
    J Natl Med Assoc; 1979 Jan; 71(1):21-3. PubMed ID: 218027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthetic cortisol antagonists in the treatment of adrenal gland hypercortisolism. Results of 8 years of use].
    Bricaire H; Luton JP
    Therapie; 1974; 29(5):645-58. PubMed ID: 4462221
    [No Abstract]   [Full Text] [Related]  

  • 10. [Further experience with the long-term treatment with aminoglutethimide in hyperfunction of the adrenal cortex (author's transl)].
    Marek J; Horký K; Gregorová I; Motlík K
    Sb Lek; 1974 Aug; 76(7):200-13. PubMed ID: 4603552
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proceedings: Case of Cushing's syndrome with remarkable improvement observed with administration of aminoglutethimide].
    Odagiri E; Yamaguchi H; Idemura H; Idemura R; Suda T
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):538. PubMed ID: 4476559
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical treatment of Cushing's syndrome with aminoglutethimide and ketoconazole.
    Kong HL; Lee KO; Cheah JS
    Singapore Med J; 1992 Oct; 33(5):523-4. PubMed ID: 1455284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglutethimide.
    Med Lett Drugs Ther; 1981 Aug; 23(16):71-2. PubMed ID: 7254130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-hormonological study of the effects of aminoglutethimide in a case of adrenal cortex carcinoma].
    Rolandi E; Bianchi G
    Arch Maragliano Patol Clin; 1971; 27(5):223-32. PubMed ID: 5172809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of aminoglutethimide (Elipten Ciba), a steroid biosynthesis blocking agent, on adrenal glands in Cushing's syndrome.
    Motlík K; Pinsker P; Stárka L; Hradec E
    Virchows Arch A Pathol Pathol Anat; 1973; 360(1):11-26. PubMed ID: 4199227
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminoglutethimide: a "side-effect" turned to therapeutic advantage.
    Hughss SW; Burley DM
    Postgrad Med J; 1970 Jul; 46(537):409-16. PubMed ID: 4920933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K; Küchel O; Gregorvá I; Stárka L
    J Clin Endocrinol Metab; 1969 Feb; 29(2):297-9. PubMed ID: 4236926
    [No Abstract]   [Full Text] [Related]  

  • 19. Capillaritis (purpura simplex) associated with use of aminoglutethimide in Cushing's syndrome.
    Stratakis CA; Chrousos GP
    Am J Hosp Pharm; 1994 Oct; 51(20):2589-91. PubMed ID: 7847422
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Hunter PR; Ross W; Hall R; Cook DB
    Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1225. PubMed ID: 4375290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.